Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors

PURPOSE: Discordance between HER2 expression in tumor tissue (tHER2) and HER2 status on circulating tumor cells (cHER2) has been reported. It remains largely underexplored whether patients with tHER2(−)/cHER2(+) can benefit from anti-HER2 targeted therapies. METHODS: cHER2 status was determined in 1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Wang, Chun, Mu, Zhaomei, Ye, Zhong, Zhang, Zhenchao, Abu-Khalaf, Maysa M., Silver, Daniel P., Palazzo, Juan P., Jagannathan, Geetha, Fellin, Frederick M., Bhattacharya, Saveri, Jaslow, Rebecca J., Tsangaris, Theodore N., Berger, Adam, Neupane, Manish, Cescon, Terrence P., Lopez, AnaMaria, Yao, Kaelan, Chong, Weelic, Lu, Brian, Myers, Ronald E., Hou, Lifang, Wei, Qiang, Li, Bingshan, Cristofanilli, Massimo, Yang, Hushan
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7299127/
https://ncbi.nlm.nih.gov/pubmed/32367460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05662-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados